NCT06000241已完成不适用
Comparison of Same Morning vs Previous Evening Dosing Regimen for Assessment of Quality of Bowel Preparation Under Anesthesia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 220
- 试验地点
- 2
- 主要终点
- ottawa score
研究概览
简要总结
220 patients are allocated randomly to the morning group (am group) or the afternoon group (pm group) and assessed by quality of bowel preparation and residual volume gastric residue.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients are able to follow the instructions of bowel preparation and have good ability of walking at least an hour.
排除标准
- •Clinical diagnosis of obstruction of bowel and sever renal and heart disease.
结局指标
主要结局
ottawa score
时间窗: a day
Two nurses observe cleaning of three parts of colon and give a score for each.
gastric residual volume
时间窗: 30 minutes
Gastric contents are suctioned and measured.
colonic residual volume
时间窗: 30 minutes
Colonic fluids are suctioned and measured.
次要结局
- adenoma detection rate(a day)
- reflux(60mins)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Treatment in morning versus evening studyTopic: Primary Care, Cardiovascular diseaseSubtopic: Other Primary Care, Cardiovascular (all Subtopics)Disease: All Diseases, OtherCirculatory SystemISRCTN18157641HS Tayside (UK)21,104
招募中
3 期
Effect of Time-of-Day Administration of Amilodipine/Valsartan on Hypertention ControlIRCT20240131060872N1Shahid Beheshti University of Medical Sciences100
已完成
2 期
To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With AsthmaAsthmaNCT01808339GlaxoSmithKline28
已完成
1 期
The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of EmpagliflozinPharmacokineticsPharmacodynamicsDiabetes MellitusNCT03895229Ain Shams University16
进行中（未招募）
不适用
Effects of morning vs evening dosing on the pharmacokinetics and pharmacodynamics of sunitinib.Renal Cell Cancer, GIST, pancreatic neuroendocrine tumorMedDRA version: 14.1Level: LLTClassification code 10067518Term: Pancreatic neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10023400Term: Kidney cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10055008Term: Gastric sarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-000425-45-NL18